GREEN VISION BIOTECHNOLOGY CORP. (GVBT) Financial Statements
GREEN VISION BIOTECHNOLOGY CORP. (GVBT) files with the U.S. Securities and Exchange Commission under CIK 0001571804. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2021
- Revenue
- $145.10 thousand
- Net Income
- -$499.78 thousand
- Total Assets
- $2.92 million
- Net Cash from Operations
- -$235.31 thousand
Fiscal year ended Dec 31, 2021. Latest periodic SEC filing: Sep 19, 2022. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for GVBT in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History